Cyclacel Pharmaceuticals, Inc. (29)
Browse by Contract Category
Contracts
-
Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron, effective as of January 1, 2023
(Filed With SEC on December 30, 2022)
-
Cyclacel Pharmaceuticals, Inc. Amended and Restated 2018 Equity Incentive Plan
(Filed With SEC on June 16, 2022)
-
Controlled Equity Offering Sales Agreement, dated as of August 12, 2021, by and among Cyclacel Pharmaceuticals, Inc. and Cantor Fitzgerald & Co
(Filed With SEC on August 12, 2021)
-
Underwriting Agreement, dated March 12, 2021, by and between Cyclacel Pharmaceuticals, Inc. and Oppenheimer & Co. Inc
(Filed With SEC on March 15, 2021)
-
Extension Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis, effective as of January 1, 2023
(Filed With SEC on December 30, 2022)
-
Description of Securities
(Filed With SEC on March 30, 2022)
-
Executed Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron
(Filed With SEC on July 12, 2021)
-
Executed Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis
(Filed With SEC on July 12, 2021)
-
Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron
(Filed With SEC on June 17, 2021)
-
Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis
(Filed With SEC on June 17, 2021)
-
Description of Securities
(Filed With SEC on March 1, 2021)
-
Form of Retirement Agreement, by and between Cyclacel Pharmaceuticals, Inc. and Judy H. Chiao, MD
(Filed With SEC on February 24, 2021)
-
Employment Extension Agreement by and between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis, dated as of January 14, 2021
(Filed With SEC on January 15, 2021)
-
Employment Extension Agreement by and between Cyclacel Pharmaceuticals, Inc. and Paul McBarron, dated as of January 14, 2021
(Filed With SEC on January 15, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 22, 2020)
-
Form of Warrant
(Filed With SEC on December 22, 2020)
-
Form of Stock Option Grant Notice and Stock Option Agreement under the Cyclacel Pharmaceuticals, Inc. 2020 Inducement Equity Incentive Plan
(Filed With SEC on November 12, 2020)
-
Cyclacel Pharmaceuticals, Inc. 2020 Inducement Equity Incentive Plan
(Filed With SEC on November 12, 2020)
-
Form of Common Warrant
(Filed With SEC on April 24, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on April 24, 2020)
-
Securities Purchase Agreement, by and among Cyclacel Pharmaceuticals, Inc. and the purchasers identified on the signature pages thereto, dated as of April 21, 2020
(Filed With SEC on April 24, 2020)
-
Co-Placement Agency Agreement, by and among Cyclacel Pharmaceuticals, Inc., Roth Capital Partners, LLC, Ladenburg Thalmann & Co. Inc., and Brookline Capital Markets, a division of...
(Filed With SEC on April 24, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on April 14, 2020)
-
Form of Warrant
(Filed With SEC on April 14, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on April 14, 2020)
-
Form of Co-Placement Agency Agreement
(Filed With SEC on April 14, 2020)
-
Form of Warrant to purchase shares of Cyclacel Pharmaceuticals, Inc.s Common Stock (previously filed as Exhibit 4.3 to the Registrants Registration Statement on Form S-1 (No....
(Filed With SEC on March 5, 2020)
-
Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul McBarron
(Filed With SEC on January 7, 2019)
-
Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro Rombotis
(Filed With SEC on January 7, 2019)
